Protective role of melatonin against diclofenac-induced acute kidney injury

Sahar Mohamed El Agaty,Sherif Khedr,Doaa Karem Metwaly Mostafa,Nardine Alfonse Wanis,Doaa Ahmed Abou-Bakr
DOI: https://doi.org/10.1016/j.lfs.2024.122936
2024-09-15
Abstract:Diclofenac (DF), a non-steroidal anti-inflammatory drug, is commonly used to relieve pain and inflammation. High doses of DF might induce acute kidney injury (AKI), particularly in elderly, a known vulnerable population. Aim: We aimed to assess the protective role of melatonin (Mel) on DF-induced AKI in aged rats and to highlight the underpinning mechanisms include, oxidative stress and inflammation focusing on microRNA-34a (miR-34a), nuclear factor erythroid-2-related factor-2/hemeoxygenase-1 (Nrf2/HO-1) and NLR family-pyrin domain containing-3 (NLRP3) inflammasome pathways, and to elucidate the possibility of epithelial sodium channel (ENaC) involvement. Materials and methods: Thirty old male Wistar rats were allocated randomly into 3 groups: Control, DF and Mel-DF groups. Key findings: Melatonin provided nephroprotective effects against DF-induced AKI via attenuating the expression of renal miR-34a and subsequently promoting the signaling of Nrf2/HO-1 with elevation of the antioxidant defense capacity and suppressing NLRP3 inflammasomes. Melatonin alleviated DF-induced hypernatremia via decreasing the ENaC expression. Renal histopathological examination revealed significant reduction in vascular congestion, mononuclear infiltration, glomerulo-tubular damage, fibrosis and TNF-α optical density. Significance: It can be assumed that melatonin is a promising safe therapeutic agent in controlling DF-induced AKI in elderly.
What problem does this paper attempt to address?